News

How farmers could fertilize more efficiently

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences

Softway Medical Group partners with contextflow to bring comprehensive AI support for lung pathologies to France

A September to remember: unprecedented wave of IMP publications

Lithoz acquires CerAMing, expands into third ceramic 3D printing technology

ÖAW gründet neues Cori-Institut für Stoffwechselforschung in Graz

Oncogenic virus: Scientists show how HPV causes skin cancer

FROM FOE TO FRIEND: HARMFUL INSECTS CAN BECOME POLLINATORS

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Core Facility Krems wird weiter ausgebaut

Forschung für Funktionserhalt und Regeneration des Innenohrs

INGE-St.-Symposien in Graz: Neurologische Spitzenforscher*innen sprechen über Multiple Sklerose und mehr

Valneva Announces Closing of Upsized €102.9 Million Global Offering

FFG gratuliert Anton Zeilinger zum Nobelpreis

Sonja Sheikh zum neuen Mitglied des Rates für Forschung und Technologieentwicklung bestellt

Self-learning Brain Stimulation Startup Brightmind.AI receives aws Funding and Starts Operations with IST cube on Board

HEARTBEAT.BIO COLLABORATES WITH BOEHRINGER INGELHEIM TO INVESTIGATE CARDIAC ORGANOIDS FOR THE DEVELOPMENT OF NEW TREATMENTS FOR PEOPLE WITH HEART DISEASES

Valneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares

Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares

PEOPLE WHO FEEL LESS PAIN ARE ALSO LESS WILLING TO HELP OTHERS